DrugBaron

FEBRUARY 16, 2024

But not everyone in drug development is playing this game. So what does the game look like to a late-stage investor or a pharma company head of R&D thinking about portfolio prioritisation? No wonder investing in drug development is so hard! But how do you know which game you are playing?

Drug Development 355

Drug Development Pharma Companies Drugs Science 355

Drug Discovery World

DECEMBER 12, 2022

The targeted programme aims to identify and accelerate novel oncology innovations into commercially-attractive assets by offering support to academics and early-stage companies. . ODP2 is seeking applications from academics and early-stage companies with a defined oncology-focused innovation.

Pharma Companies 130

Pharma Companies Drugs Clinical Trials Research 130

Drug Discovery World

DECEMBER 27, 2023

In this episode, Kelland shares what she means by the ‘next pandemic’, the lessons learnt from the Covid-19 pandemic, and the role of global health organisations and pharma companies going forward. Listen here. Thereafter, the series featured Dr Michael Pace, Global & Strategic Feasibility Expert at Rho. Listen here. Listen here.

Targeted Protein Degradation 173

Targeted Protein Degradation Clinical Trials Pharma Companies Drug Development 173

The Pharma Data

DECEMBER 20, 2020

UK drug developer Scancell said it has chosen a COVID-19 vaccine candidate, SN14, from more than a dozen potential products to advance to a clinical trial. . SN14 works by targeting the coronavirus’ nucleocapsid and spike proteins to prevent viral replication using the company’s ImmunoBody DNA vaccine technology.

Clinical Trials 52

Clinical Trials Pharma Companies Vaccine Trials 52

Drug Discovery World

SEPTEMBER 15, 2023

Spanning artificial intelligence, theranostics, radiopharmaceuticals, quantum simulation and small regulatory RNA, the top stories this week all cover cutting-edge technologies and techniques making a huge impact on modern drug discovery and development.

Pharma Companies 130

Pharma Companies Drugs RNA Vaccine 130

Drug Discovery World

AUGUST 22, 2023

Originator pharma companies are developing ever more complex products, which are transforming the medical landscape, but their cost places an increasing burden on healthcare budgets worldwide. Opportunities Originator pharma companies are developing more and more complex products these days.

Production 130

Production Pharma Companies Clinical Trials FDA 130

Drug Discovery World

NOVEMBER 11, 2022

Pharma companies team-up to reduce emissions . Seven pharmaceutical companies have announced a joint initiative to reduce near-term emissions and help develop net zero health systems. . . . . .

Pharma Companies 130

Pharma Companies Drugs Pharmaceutical Companies Disease 130

Reprocell

NOVEMBER 1, 2022

Pharma companies are legally required to test novel drugs in animal models before beginning human trials. And while animal testing has progressed thousands of therapeutics that we use today, it is not without its experimental and ethical downfalls.

Animal Testing 52

Animal Testing Pharma Companies Laboratories Science 52

biobide

FEBRUARY 2, 2024

This is why not many Pharma companies specifically specialize in discovering and developing pediatric cancer treatments; a great example of advancing new therapies for childhood cancer is the biotech Oncoheroes. This treatment was developed by performing a chemical screening on zebrafish.

Disease 59

Disease Medical Schools Pharma Companies Clinical Trials 59

Drug Discovery World

SEPTEMBER 28, 2022

Its application in pharma, most commonly in drug discovery, has been steadily growing with global partnerships between tech vendors and pharma companies becoming more commonplace. NEC, the Japanese IT and electronics corporation, has pivoted towards drug discovery with a focus on personalised medicines.

Pharma Companies 130

Pharma Companies Hospitals Clinical Trials Drugs 130

PPD

JULY 13, 2023

At the beginning of 2023, the PPD clinical research business of Thermo Fisher Scientific surveyed 120 drug developers across the pharmaceutical, biopharmaceutical and biotechnology sectors (referred to collectively as “pharma”) to learn more about sponsors’ current needs for site and patient recruitment services.

Pharma Companies 52

Pharma Companies Clinical Trials Trials Clinical Research 52

Alta Sciences

APRIL 5, 2024

The mini documentary explores transformation in the slow-to-change drug development industry. Leaders from Altasciences dive into the obstacles and inefficiencies of the traditional outsourcing relationship between CROs and drug sponsors, and how Altasciences has broken from tradition to address these challenges.

Drug Development 52

Drug Development Pharma Companies Marketing International 52

Drug Discovery World

MARCH 29, 2023

Antibiotic development According to Politico, the European Medicines Agency is investigating a chronic shortage in antibiotics across Europe, where almost every country is reporting gaps in supplies – 25 out of the 27 EU countries have reported local shortages, the agency’s Chief Medical Officer, Steffen Thirstrup, told a press briefing 6.

Clinical Trials 130

Clinical Trials Biosimilars Pharma Companies Production 130

Drug Discovery World

OCTOBER 16, 2023

From the Beatson Institute for Cancer Research in Glasgow, to Edinburgh Drug Discovery in the University of Edinburgh’s Institute for Genetics and Cancer (IGC). At ELRIG’s Scottish Research and Drug Development Forum meeting, DDW’s Diana Spencer provided a snapshot of drug discovery in Scotland.

Drugs 189

Drugs Science Therapies Targeted Protein Degradation 189

Drug Target Review

MARCH 15, 2024

Cultural differences between the UK and mainland Europe were still quite different then but we settled in Southampton and I later went to University in Brighton, studied for a D.Phil, and found a job at a Pharma company. She has held leadership positions in Project Management, Technical Operations, and Business Development.

Organic Chemistry 59

Organic Chemistry Pharma Companies Clinical Trials Pharmaceuticals 59

Drug Discovery World

OCTOBER 6, 2022

With key players including AstraZeneca, Bayer, Novartis and Pfizer pushing the boundaries of drug development, the reason behind this growth is evident. According to McKinsey & Company: “Europe’s complex biotech landscape comprises hundreds of companies, dozens of countries, and multiple paths to innovation and financing… .

Targeted Protein Degradation 130

Targeted Protein Degradation Drugs Pharma Companies Marketing 130

Drug Discovery World

NOVEMBER 16, 2022

It’s hoped that through this, scientists will be able to better predict how drug molecules perform in the body, leading to expedited drug development and better outcomes for patients. . That means if two pharma companies are trying to grow say a cardiac organoid, they won’t be consistent across the board,” he says. .

Pharma Companies 243

Pharma Companies Science Research Drugs 243

Drug Discovery World

JANUARY 21, 2024

Bushell will discuss the history and technological underpinnings of induced proximity, the lessons learned from the PROTAC (proteolysis-targeting chimeric) example, and how technology can create enhancement-targeting chimeric, or ENTAC, drugs and fully realise the potential of targeted protein enhancement. Is pharma’s commercial model dying?

Vaccine 130

Vaccine Computational Chemistry Animal Testing Engineering 130

Drug Discovery World

AUGUST 5, 2022

Ian Hollingsworth, Associate Director of product development at Boyds, the global drug development consultancy, explains the benefits to the drug development lifecycle of building strong partnerships with external consultants, and when and how to get the best from them. Why sponsors use external consultants.

Drug Development 130

Drug Development Drugs Pharma Companies International 130

Drug Discovery World

MAY 6, 2024

Even before this, however, Amsterdam was established as an important centre for drug development. Under the partnership, KWF will provide funding to enable the development of select early phase clinical programmes through Cancer Research UK’s Centre for Drug Development (CDD).

Drugs 147

Drugs Science Molecular Biology Clinical Trials 147

H1 Blog

JULY 5, 2023

The success of drug development and approval relies heavily on the ability to identify diverse patient populations for clinical trials. From trial site feasibility to successful trial recruitment, diversity within a trial population helps ensure the safety and efficacy of drugs that reach the market.

Clinical Trials 52

Clinical Trials Drugs Trials Pharma Companies 52

Drug Discovery World

OCTOBER 4, 2022

Several of the large pharma companies have recently re-entered the dementia field. These are exciting developments for both caregivers as well as drug developers which will enable the more rapid development of new treatment modalities, such as OLX-07010,” he adds. .

Disease 130

Disease Small Molecule Compound Screening Clinical Development 130

Drug Discovery World

JANUARY 24, 2023

In early November 2022, two Alzheimer’s drugs were tested head-to-head in a first-ever virtual clinical trial 3. ” 4,5,6 Asking the right questions Norstella is a newly formed company that aims to guide life sciences companies through drug development so patients can access therapies quicker.

Clinical Trials 242

Clinical Trials Trials Drugs Treatment 242

Drug Discovery World

JULY 18, 2022

Troy Groetken of intellectual property and technology law firm McAndrews, Held & Malloy tells Lu Rahman how pharma companies can take this data from where it currently stands (drug design and development) to a more clinical level. Key opportunties. His advice? Up front collection and controlling your data! “As

Clinical Trials 130

Clinical Trials Therapies Pharmaceuticals Science 130

Drug Discovery World

AUGUST 4, 2023

With so many exciting novel treatments emerging from the labs, biotechs and pharma companies need to understand the potential unknowns as well as the known considerations if they are to optimise their impact in the real world.

Therapies 130

Therapies Pharma Companies Treatment Marketing 130

Drug Discovery World

OCTOBER 25, 2023

AI and ML speeds up the process significantly by using pattern matching and superior computational methods to guide experimentation so that scientists can avoid redundancies and mistakes.    MT: What does VeriSIM Life do, and how does this influence drug discovery? MT: Has the company enabled any recent breakthroughs with its technology?

Pharma Companies 279

Pharma Companies Clinical Trials Drugs Drug Development 279

Drug Discovery World

DECEMBER 14, 2023

An incubator for biotech Just outside Glasgow, Motherwell is another hotspot for drug discovery and has recently benefitted from major investment. Antibody Analytics is a Motherwell-based biotechnology research company providing drug developers with the data required to expedite new healthcare solutions.

Drugs 189

Drugs Science Research Laboratories 189

H1 Blog

MAY 4, 2023

Insights for Thought Leading Stakeholder Engagement to Decrease Medication Non-Adherence Pharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education.

Pharmaceutical Companies 52

Pharmaceutical Companies Clinical Research Pharma Companies Pharmaceuticals 52

DrugBaron

JANUARY 31, 2024

Billions of dollars have been invested in companies promising to “revolutionise pharma R&D” through the application of artificial intelligence – but it is now clear that global pharma companies, and not just tech bro’s, are buying into the claims. And there is no doubt that there is plenty of room for improvement.

Pharma R&D 165

Pharma R&D Science Small Molecule Pharma Companies 165

Drug Discovery World

FEBRUARY 10, 2023

A good part of half of those are within pharma. The pharma companies that are based in Sweden, are international ones, and often have a marketing and commercial side but maybe not that drug development side that really brings that key focus area between the development and commercialisation.”

Science 130

Science Drugs Pharmaceutical Companies Pharmaceuticals 130

PerkinElmer

FEBRUARY 18, 2021

Which high throughput screening (HTS) approach is the most productive in finding hits for drug development: target-based or phenotypic? By a 3:1 margin, PerkinElmer found top Pharma screens for a specific target. Pharma companies must improve productivity and efficiency amidst rising R&D costs.

Biochemical Assays 52

Biochemical Assays Drugs Small Molecule Pharma Companies 52

The Pharma Data

OCTOBER 20, 2020

MD Anderson has historically collaborated with biotechs and pharma companies to conduct cancer therapy research. Through investment from the Cancer Focus Fund and the support of MD Anderson, we hope to advance worthwhile new treatments past the traditional hurdles in the drug development process.” . Source link.

Clinical Trials 52

Clinical Trials Pharma Companies Therapies Trials 52

Vial

MARCH 1, 2024

Leading Global CROs To advance new therapies, pharma, biotech, and medical device sponsors engage CROs to help navigate the complex landscape of drug development and regulatory pathways and to manage clinical trials efficiently, ethically, and in compliance with good clinical practice ( GCP ) standards. of total revenue).

Clinical Trials 52

Clinical Trials Clinical Research Laboratories Trials 52

The Pharma Data

OCTOBER 16, 2020

As pharma companies search for solutions to avoid cancelling or delaying clinical trials, virtualizing trials are fast becoming commonplace during the Covid-19 pandemic. With many nationwide and regional lockdowns coming into force, virtual clinical trials are proving to be an effective way to monitor patients remotely.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Clinical Research 52

Alta Sciences

MARCH 27, 2024

Up Close and Personal With Eryn Corriveau, MSc, Senior Director, Drug Development and Regulatory Strategy nbartlett Wed, 03/27/2024 - 20:21 Here at Altasciences, Eryn is responsible for guiding regulatory strategies , conducting gap analyses, and leading interactions with regulatory agencies dur ing early drug development.

Drug Development 52

Drug Development Medical Schools Pharma Companies Drugs 52

Predictive Oncology

FEBRUARY 7, 2023

That means a lot of wasted effort and resources for drugmakers given that even before a molecule enters Phase I trials, typically five to eight years of development have already been invested in the product. This is going to disrupt the way that drug development is done,” Bush said, by changing the way companies choose drug indications.

Clinical Trials 52

Clinical Trials Pharmaceutical Companies Trials Pharmaceuticals 52

Drug Discovery World

JANUARY 24, 2024

MT: What technologies are Fibrocor Therapeutics utilising to advance its drug development process? Since they are rare, medications we develop for these diseases are eligible for an Orphan Drug Designation (ODD) from the regulatory authorities if the programs show a high degree of scientific innovation.

Small Molecule 147

Small Molecule Research Pharma Companies Disease 147